Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

NCT00476229 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Leukemia

Interventions

DRUG: Thymoglobulin
RADIATION: Total Lymphoid Irradiation
PROCEDURE: Peripheral Blood Stem Cell Infusion
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]